+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bevacizumab"

Liver Cancer Therapeutics Market Analysis & Forecast 2024-2034: Market By Type; By Therapy; By Route of Administration; By Distribution Channel; and By Region - Product Thumbnail Image

Liver Cancer Therapeutics Market Analysis & Forecast 2024-2034: Market By Type; By Therapy; By Route of Administration; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Liver Cancer Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Liver Cancer Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 120 Pages
  • Global
From
Gastric Cancer Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Gastric Cancer Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 112 Pages
  • Global
From
Immune Checkpoint Inhibitors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Immune Checkpoint Inhibitors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 119 Pages
  • Global
From
Solid Tumor Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Solid Tumor Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 114 Pages
  • Global
From
Metastatic Colorectal Cancer Drugs Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Thumbnail Image

Metastatic Colorectal Cancer Drugs Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • October 2023
  • 190 Pages
  • Global
From
Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Class, By Tumor Type, By Distribution Channel, By Region - Product Thumbnail Image

Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Class, By Tumor Type, By Distribution Channel, By Region

  • Report
  • November 2022
  • 117 Pages
  • Global
From
Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • November 2023
  • 306 Pages
  • Global
From
Small Cell Lung Cancer (SCLC) Market Report and Forecast 2024-2032 - Product Thumbnail Image

Small Cell Lung Cancer (SCLC) Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Colorectal Cancer KOL Interview - UK - Product Thumbnail Image

Colorectal Cancer KOL Interview - UK

  • Newsletter
  • March 2025
  • 14 Pages
  • United Kingdom
Colorectal Cancer KOL Interview - US, Northeast - Product Thumbnail Image

Colorectal Cancer KOL Interview - US, Northeast

  • Newsletter
  • March 2025
  • 14 Pages
  • United States
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
Metastatic Colorectal Cancer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Metastatic Colorectal Cancer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • February 2024
  • 88 Pages
  • Global
From
Triple Negative Breast Cancer Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Triple Negative Breast Cancer Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 90 Pages
  • Global
From
Bevacizumab Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Bevacizumab Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 77 Pages
  • Global
From
Bevacizumab Biosimilar Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Bevacizumab Biosimilar Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Product Type

  • Report
  • April 2023
  • 119 Pages
  • Global
From
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 871 Pages
  • Global
From
Colorectal Cancer Diagnosis and Therapeutic Updates - Product Thumbnail Image

Colorectal Cancer Diagnosis and Therapeutic Updates

  • Book
  • June 2022
2025 Global Forecast for Bevacizumab Biosimilar Market (2026-2031 Outlook)-High Tech Outlook Report - Product Thumbnail Image

2025 Global Forecast for Bevacizumab Biosimilar Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • January 2025
  • 132 Pages
  • Global
From
Colon Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Colon Cancer Treatment Drugs Markets in China

  • Report
  • August 2024
  • 199 Pages
  • China
From
Loading Indicator

Bevacizumab is a monoclonal antibody used in the treatment of various types of cancer. It is used in combination with other drugs to treat metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, metastatic renal cell carcinoma, and metastatic breast cancer. Bevacizumab works by inhibiting the growth of new blood vessels, which can help slow the growth of tumors. It is administered intravenously and is typically given in combination with other chemotherapy drugs. Bevacizumab is a widely used drug in the oncology market, and is one of the most prescribed drugs for cancer treatment. It is used in combination with other drugs to treat a variety of cancers, and is often used in combination with chemotherapy. Bevacizumab has been shown to be effective in treating certain types of cancer, and is generally well tolerated. Some companies in the Bevacizumab market include Genentech, Roche, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more